Use of rapamycin for the treatment of cognitive deficits associated with Down syndrome.

摘要

Use of rapamycin for the treatment of cognitive deficits associated with Down syndrome.; The present invention relates to the use of a composition comprising an mTOR inhibitor, where the inhibitor is selected from rapamycin, temsirolimus, everolimus or deforolimus. Furthermore, the present invention relates to the use of these inhibitors, preferably rapamycin for the manufacture of a medicament for the treatment of cognitive impairment associated with Down syndrome.